We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
47 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZILBRYSQ zilucoplan (as tetrasodium) 23.0 mg/ 0.574 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZILBRYSQ zilucoplan (as tetrasodium) 16.6 mg/ 0.416 mL solution for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: zilucoplan tetrasodium.
-
Prescription medicine registrationActive ingredients: bimekizumab.
-
Apr-2024Prescription medicine evaluationActive ingredient: bimekizumab.
-
Nov-2023Prescription medicine evaluationActive ingredient: rozanolixizumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bimzelx bimekizumab 160 mg/1 mL solution for injection safety syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bimzelx bimekizumab 160 mg/1 mL solution for injection auto-injector.